£0 – £63.29

OBN BioTuesday: Spotlight on Neurodegenerative Diseases

Event Information

Share this event

Date and Time

Location

Location

The Babraham Institute

Babraham

CB22 3AT

United Kingdom

View Map

Event description

Description


We are pleased to announce details of a special edition BioTuesday event that we are holding at the Babraham Institute in Cambridge which will provide a ‘Spotlight on: Neurodegenerative Diseases’.

Neurodegenerative diseases are incurable conditions in which nerve cells gradually degenerate, or die, for reasons that are not yet understood. Neurodegenerative diseases include Alzheimer’s, Parkinson's, Huntington's, Motor Neurone disease, Creutzfeldt-Jakob and Multiple Sclerosis, many of which give rise to dementia.

Around 850,000 people in the UK have dementia with the number of people affected projected to reach 2 million by 2051. There is currently no cure for any of the neurodegenerative conditions that give rise to dementia, which represents one of the toughest medical and economic challenges facing our society today.

During the event, a line-up of expert speakers will provide a comprehensive and fascinating update on the latest research results and treatments available for neurodegenerative disease, including dementia, along with a review of government funding, a private investment industry update, and news from one of five of the UK’s ‘Dementia Research Institutes’ Centre’s of Excellence.

We will also hear case studies from four of the most innovative companies in the UK who are working in the neurodegenerative space.

17:30 Registration and networking

18:00 Welcome and introductions from Dr John Harris, CEO of OBN (UK) Tony Jones, CEO of One Nucleus

18.10-18.25 Michael Wakelam, Director, Babraham Institute – will share an update on the Babraham ‘Healthy Ageing’ themed research (TBC)

18.25 – 18.40 Dr David Brown: ‘Practical Lifestyle for Healthy Ageing and Reduced Neurodegeneration’

18.40 – 19.00 Tetsuyuki Maruyama, Chief Scientific Officer, Dementia Discovery Fund,

19.00 – 19.20 Dr Joanna Wolak, Principal Research Scientist at Eli Lilly


Company Showcase Presentations


19.20 – 19.30 Jenny Barnett, Chief Scientific Officer, Neuroscience Digital Health, Cambridge Cognition

19.30 – 19.40 Su Metcalf, Founder and CSO, LIFNano Therapeutics

19.40 – 19.50 Final Company Showcase Presentation

19:50 Panel discussion and Q&A

20.20 Networking over drinks and nibbles

21:30 Evening close


Share with friends

Date and Time

Location

The Babraham Institute

Babraham

CB22 3AT

United Kingdom

View Map

Save This Event

Event Saved